We undertook a study of molecular interference of nuclear orphan receptors. Nuclear receptor response element-1 (NRRE-1) from the human medium-chain acyl coenzyme A dehydrogenase (MCAD) gene promoter was shown to contain three hexamer elements (site 1 through 3) that are known to interact with a number of nuclear receptors including chicken ovalbumin upstream promoter transcription factor (COUP-TF) and estrogen-related receptor alpha (ERRα). We demonstrated that the peroxisome proliferator-activated receptor alpha/9-cis-retinoic acid receptor alpha (PPARα/RXRα) heterodimer complex can also bind to the two hexamer repeat sequences (between site 1 and site 3) arranged as an everted imperfect repeat separated by 14 bp (ER14). Mutations of the putative core elements have shown that these three sites are differentially involved in ERRα and PPARα/RXRα binding. Homodimer of ERRα was shown to interact between site 1 and site 3 (ER14). To date, no nuclear receptor is known to bind to response elements over such long intervals. Interestingly, site 1 was shown to be essential for ERRα binding while site 3 supports its binding only in the presence of site 1. Furthermore, it was shown that the binding profile of ERRα and PPARα/RXRα are competitive rather than making a high order complex within NRRE-1. At the cellular level, transcriptional activation driven by the PPARα/RXRα complex was counteracted by the expression of ERRα in HeLa cells. These results suggest that ERRα and PPARα/RXRα could interfere with each other's function through binding to similar DNA elements, thereby finetuning the transcriptional outcome of the target gene. Our findings suggest a mechanism whereby multiple nuclear receptors can activate or repress DNA binding or transcription via a single pleiotropic regulatory element.
Introduction
The nuclear hormone receptors are a family of ligand-induced transcription factors that bind to specific DNA response elements and play crucial roles in a wide variety of cellular processes (excellent reviews are found in Mangelsdorf et al. 1995 , Aranda & Pascual 2001 , Willson & Moore 2002 . Transcriptional regulation by nuclear hormone receptors involves participation of basal transcription factors, including TATA-binding protein and TFIIB, and other cofactors, known as nuclear transcriptional coactivators or corepressors, that form bridges between nuclear receptors and the basal transcription machinery (Polak 1997 , Edwards 1999 , Robyr et al. 2000 . Many nuclear hormone receptors possess bimodal transcriptional properties and are capable of either repressing or activating target gene transcription, depending on the status of the ligand, the promoter and the nature of the host cell (Polak 1997 , Gottlicher et al. 1998 , Gay et al. 2002 . In the absence of ligand, many receptors actively repress transcription via direct interactions with co-repressors such as SMRT (silencing mediator for retinoid and thyroid receptors), N-CoR (nuclear HDAC) or Sin3A (Rosenfeld & Glass 2001) . Upon ligand binding, these co-repressor complexes dissociate and the agonist-bound receptors interact with multiprotein coactivator complexes that contribute to the transmission of activating signals to the general transcription machinery. It is hypothesized that the ability of this complex to deacetylate histones results in an altered chromatin state that is inhibitory to transcription (Rosenfeld & Glass 2001 , Hsiao et al. 2003 .
The nuclear receptors bind either as monomers or as homo-or heterodimers to response elements composed of a single core motif A/GGGTCA or to direct, palindromic or inverted repeats of the core motif spaced by one or more nucleotides (Forman & Evans 1995 , Khorasanizadeh & Rastinejad 2001 . Target gene recognition is specified by the DNA binding domain (DBD) which is composed of two zinc finger motifs that fold into two helical domains and a third helix extending from the second zinc finger (Freedman & Luisi 1993) . Response elements for these receptors generally consist of paired hexamer sites that bind receptor homo-or heterodimers, with specificity determined, at least in part, by the relative orientation and spacing of hexamers (Forman & Evans 1995 , Khorasanizadeh & Rastinejad 2001 . However, some members of these receptors are known to bind to the single hexamer sites as monomers (Kutoh et al. 2000 , Lee & Moore 2002 .
The estrogen-related receptor (ERR ) is an orphan member of the nuclear hormone receptor superfamily. A cDNA encoding this protein was originally isolated on the basis of sequence homology in its DNA-binding domain with estrogen receptor (ER , Giguere et al. 1988 , Giguere 2002 . While ERR displays significant homology to the estrogen receptor, it does not bind estrogens in vitro nor is its transcriptional activity modulated by estrogens (Yang et al. 1996) . ERR binds as a monomer to the extended halfsite TNAAGGTCA (core element underlined; Johnston et al. 1997 , Sladek et al. 1997 , Vanacker et al. 1998 or as a heterodimer or homodimer to the consensus estrogen response element (Pettersson et al. 1996 , Vanacker et al. 1999 . In the adult mouse, ERR is most highly expressed in kidney, heart, and brown and white adipocytestissues which preferentially metabolize fatty acids and show a high capacity of fatty acid -oxidation. These results suggest that ERR may play a role in determining the metabolic potential of these tissues. ERR was shown to interact with the nuclear receptor response element-1 (NRRE-1) of the medium-chain acyl coenzyme A dehydrogenase (MCAD) gene that is the key enzyme of the mitochondrial fatty acid -oxidation cycle (Vega & Kelly 1997) . Given this background, ERR appears to play a role in lipid metabolism. The transcriptional property of ERR is still controversial. ERR has been shown to have no effect or to repress transcription of the MCAD gene (Sladek et al. 1997) and SV40 major promoter (Wiley et al. 1993 , Johnston et al. 1997 . However, ERR was also reported to activate transcription through the SFRE in a cell-specific manner (Bonnelye et al. 1997 , Vanacker et al. 1999 .
Peroxisome proliferator-activated receptors (PPARs) are also members of the nuclear hormone receptor superfamily. Their ligand-activated transcription factors respond to a class of chemical agents termed peroxisome proliferators that include the fibrate family of hyperlipidemia drugs, phthalate ester plasticizers, herbicides, pesticides, antidiabetic thiazolidinediones as well as certain fatty acids (reviewed by Takahashi & Kawada 2001) . PPARs heterodimerize with the 9-cis-retinoic acid receptor, RXR , and bind to specific peroxisome proliferator-response elements (PPREs) found up-stream of target genes. PPREs have been identified in the promoter region of a number of genes involved in fatty acid metabolism. PPREs consists of a direct repeat of the hexameric motif TGACC(T/C) separated by one nucleotide (referred to as DR1), and serve to bind not only PPARs but also several other nuclear hormone receptors that differentially modulate PPAR function. Nuclear hormone receptors shown to modulate PPAR function include chicken ovalbumin upstream promoter transcription factor (COUP-TF) (Miyata et al. 1993 ), hepatocyte nuclear factor-4 (Winrow et al. 1994) , TR (Hunter et al. 1996) , LXR (Miyata et al. 1996) , and RZR (Winrow et al. 1998) . Therefore, transcriptional regulation from PPREs is a net aggregate response generated, in part, by the availability of PPARs and other factors that bind PPREs, the complexity of response elements, and the interplay of PPARs with other nuclear hormone receptors and cofactors, including corepressors and coactivators. This complex interaction of various factors and elements ensures that the correct transcriptional response to extra-and intracellular stimuli will be elicited from appropriate target genes.
In this study, we studied the interference of DNA binding and transcriptional properties of ERR and PPAR /RXR within the NRRE-1 from the human MCAD gene. Our findings suggest a mechanism whereby multiple nuclear receptors can activate or repress transcription via a single pleiotropic element.
Materials and methods
All buffers and solutions were prepared and standard molecular biology techniques were used as described in Sambrook et al. (1989) .
Plasmid constructs
Rat PPAR , human RXR , mouse ERR expression vectors (Ijpenberg et al. 1997 , Sladek et al. 1997 , Kassam et al. 1999 , kind gifts from Drs Rachubinski and Giguere) were used for in vitro expression in reticulocyte lysate and transfection assays. For NRRE1/pBLCAT2 reporter plasmid, double stranded NRRE-1 wild-type (WT) as well as mutated (M) oligonucelotides designed to carry the HindIII (5 ) and BamHI (3 ) restriction sites at each end were subcloned into the HindIII/BamHI sites present upstream of the thymidine kinase (TK) promoter of the pBLCAT2 plasmid (Luckow & Schutz 1987) . These plasmid DNAs were prepared using Qiagen EndoFree columns (Qiagen, Düsseldorf, Germany) for subsequent transfection experiments.
In vitro transcription/translations
Transcription/translation of cDNAs encoding PPAR , RXR and ERR was performed using the TNT T7-coupled rabbit reticulocyte lysate system according to the manufacturer's protocol (Promega, Madison, WI, USA). Synthesized proteins were used for gel retardation assays.
Oligonucleotides
The following complementary synthetic oligonucleotides including the original flanking sequences were synthesized (Hitachi, Kawagoe, Japan), annealed and used for the gel retardation assay. 
Gel retardation assays
In vitro synthesized proteins in reticulocyte lysates as above were prepared and the gel retardation assays were performed as described previously (Kutoh et al. 1992) . Briefly, binding reactions of 20 µl were carried out in buffer containing 10 mM Hepes (pH 7·9), 2·5 mM MgCl 2 , 10% glycerol (v/v), 1 mM dithiothreitol, 1 µg poly (dl-dC), 50 mM KCl, 2·5 fmol 32 P-labeled oligonucleotides and 1 µl reticulocyte lysate. Competitors (unlabeled probes) were added at the same time as the radiolabeled probes. Incubation was carried out at room temperature for 15 min. Free and bound DNA were separated by electrophoresis on non-denaturing 4% polyacrylamide gels (acrylamide bis 29:1, cross linked) with 0·5 TBE (1 TBE: 90 mM Tris-borate, 1 mM EDTA) as running buffer. The gels were dried and analyzed by autoradiography. For some experiments, intensities of the signal were quantified using Adobe Photoshop 5·0 image analyzing software (Vero Beach, FI, USA).
Cell culture, transfection and reporter gene assays
HeLa cells (purchased from ATCC, Manassan, VA, USA and RIKEN, Tsukuba, Japan) were cultured in Dulbecco's modified Eagle's medium (DMEM, Life Technologies). The medium was supplemented with sodium bicarbonate 50 mM, penicillin 100 U/ml, streptomycin 50 µg/ml and 10% fetal calf serum (FCS) and the cells were grown in a 95% air/ 5% CO 2 atmosphere at 37 C. Ten micrograms of each CAT reporter plasmid together with varying amounts of expression vector (ERR , PPAR and RXR ) and 1 µg of the -galactosidase (pSV-gal, Promega, Madison, WI, USA) plasmid were transfected using the calcium phosphate transfection method (Protocols and Application Guide, Promega). The cells were harvested 48 h after the transfection and the CAT was measured using a CAT ELISA kit (Roche Diagnostics, Basel, Switzerland). To check the transfection efficiency, -gal activities were measured with a -gal ELISA kit (Roche Diagnostics).
Preparation of RNA and RT-PCR
Total RNAs of the transfected cells were prepared using Trizol reagent according to the manufacturer's protocol (Life Technologies, Paisley, Scotland). One microgram RNA was reverse-transcribed by 500 ng oligo-dT primer, 1 µl 10 mM dNTPs and 200 units of SuperScript II reverse transcriptase (all from Life Technologies) in a total volume of 20 µl according to the manufacturer's protocol. After the reaction, the mixture was heated at 65 C for 10 min and 80 µl H 2 O were added. Subsequently, PCR reactions were performed in a total volume of 100 µl containing 3 µl cDNA, 1 µl of 20 mM of each specific ERR primers, 1 µl of 10 mM dNTPs and 2·5 U Ex-Taq DNA polymerase (Takara, Kyoto, Japan).
PCR primers used were -ERR forward: ATAACTCCAAGCAGGCTCCA; ERR reverse: CAAAAGCGGTTTCTCTTTGC. For control, glyceraldehyde phosphate dehydrogenase (GA, Kutoh et al. 1998 ) specific primers were used.
After an initial denaturation at 93 C for 2 min, PCR was carried out in 30 cycles (from step 1 to step 3) using Gene Amp 9700 (Perkin Elmer, Norwalk, CT, USA) as follows: step 1: 93 C for 1 min (denaturation); step 2: 60 C for 1 min (annealing); step 3: 72 C for 2 min (reaction); step 4: 72 C for 7 min (final elongation). The PCR products were loaded on 1·5% agarose 0·5 TBE gel and the images of the ethidium bromide stained gels were obtained.
Results

ERR and PPAR /RXR complex bind to the NRRE-1
NRRE-1 is a pleiotropic element capable of conferring transcriptional properties by other nuclear receptors including ERR , RAR , or COUP-TFs (Vega & Kelly 1997 and references therein) . NRRE-1 is composed of three potential nuclear receptor half binding site sequences (Fig. 1) . Specifically, the 5 hexamer (site 1, AGGTCA) is in the antisense orientation 8 bp and 14 bp upstream of an imperfect sense repeat (site 2 and site 3, GGGTAA and AGGTGA respectively). The architecture of NRRE-1 is unique compared with those of other previously identified nuclear receptor response elements. The receptor hexamer binding sites within this element do not correspond to prototypical receptor response elements such that sequences contributing to receptor function are not predictable from previous reports. Accordingly, we next directly explored the receptor-DNA interactions in detail.
PPAR and RXR are known to form a heterodimer complex and this complex was shown to bind to the response element named PPRE (Kliewer et al. 1992 , Gearing et al. 1993 . We then addressed the question of whether, in addition to ERR , the PPAR /RXR complex could interact with the NRRE-1, although NRRE-1 is clearly distinct from a conventional PPRE. To answer this question, an in vitro gel retardation assay was performed using a radiolabeled NRRE-1 together with in vitro expressed ERR or PPAR /RXR complex. As shown in Fig. 2A , both ERR and the PPAR / RXR protein complex also bind to the wild-type NRRE-1. As expected, PPAR or RXR alone failed to bind to the DNA ( Fig. 2A) . To check the specificity of the DNA-protein complex, a molar excess of unlabeled competitors (SFRE, AoxPPRE or OCT) were included (Fig. 2B) . SFRE is a known copy of the ERR binding site from the SF-1 gene (Bonnelye et al. 1997) and AoxPPRE is a known PPAR /RXR binding site from the fatty acylCoA oxidase (Kassam et al. 1999) . A 50-fold molar excess of specific competitors (SFRE or AoxPPRE) was able to eliminate the DNA-protein complex whereas the same amounts of non-specific competitors (OCT) were unable to do so. These experiments confirmed that both ERR and PPAR /RXR specifically interact with the NRRE-1.
Binding site analysis
NRRE-1 contains three hexamer binding sequences separated by 8 bp (site 1 and site 2), 14 bp (site 1 and site 3) or 0 bp (site 2 and site 3) which may be the target sites for nuclear receptor binding as indicated in Fig. 1 . Since the nuclear hormone receptor binding to elements with 8 or 14 bp hexamer spacing is currently unknown, we examined the role of these sites by mutational analysis. As a first step in identifying the receptor binding sites in this complex element, systematic mutations were introduced within the potential nuclear receptor half binding sites (M1 through M6, see Fig. 1 ). As presented in Fig. 3A , mutations in site 1 (M1) had completely lost ERR binding while mutations in site 3 (M3) had a partial reduction. Mutations in site 2 (M2) had little, if any, effect on ERR binding. One interesting observation is that site 1 appears to be essential for ERR binding to NRRE-1, since mutations within site 1 had completely lost the binding activity, irrespective of the presence of an intact site 2 and site 3 (M1, M4, M5). The presence of an intact site 1 with mutated site 2 and/or site 3 (M2, M3 and M6) still had efficient, but lower levels of DNA binding activity in comparison to the wild type (WT). This phenomenon was confirmed by using these mutated as well as WT oligonucleotides as cold competitors (Fig. 3B) . The ERR /NRRE-1-dependent DNA-protein complex was strongly inhibited with a 50-fold molar excess of WT, M2 or SFRE while other competitors (M1, M3, M4, M5, M6, OCT) had little effect. These results show the differential importance of these sites for ERR binding. In order to find out the importance of this phenomenon, we undertook gel retardation assays using WT as well as mutated NRRE-1 (M1 through M6) with increasing amounts of ERR ( Fig. 3C i and ii) . The intensity of the ERR -dependent DNA-protein complex was measured and its graphic display is shown in Fig.  3D i and ii. These results indicate that site 1 is essential for ERR binding while site 3 supports ERR binding only in the presence of an intact site 1. Site 2 appears to be involved in little, if any, ERR binding.
In the case of PPAR /RXR , mutations in either site 1 or site 3 (M1 and M3) had reduced DNA binding activities while mutations in site 2 (M2) had little, if any, effect (Fig. 4A) . However, mutations in both site 1 and site 3 lost their DNA binding activity (M5) whereas mutations in either site 1 (M4) or site 3 (M6), irrespective of the integrity of site 2, had reduced levels of DNA binding activity. This phenomenon was confirmed by using these mutated as well as WT oligonucleotides as cold competitors (Fig. 4B) . The PPAR /RXR -dependent DNA-protein complex was strongly inhibited with a 50-fold molar excess of WT, M2, or AoxPPRE, while competitors harboring mutations in either site 1 or site 3 (M1, Figure 2 ERRα and PPARα/RXRα heterodimer complex can bind to NRRE-1. In vitro transcribed/translated ERRα, PPARα, and RXRα were tested for their ability to bind NRRE-1.
32 P-labeled double-stranded NRRE-1 probes were incubated with 2 µl of in vitro transcribed/translated ERRα or PPARα/RXRα in reticulocyte lysate and the DNA binding was analyzed by gel retardation assay as described in Materials and methods. In some experiments (B), a 50-fold molar excess of unlabeled competitor oligonucleotides (comp) (SFRE, AoxPPRE, or OCT) was added to the reaction. The DNA-protein complex is indicated with an arrow. Free probes are shown at the bottom of the gel (F).
M3, M4, M6) reduced the intensity of the DNA-protein complex. However, M5 (mutations in both site 1 and site 3) had no such effect. These results show the differential importance of three sites for PPAR /RXR binding. In order to further analyze this phenomenon, we undertook gel retardation assays using WT as well as the mutated NRRE-1 (M1 through M6) with increasing Interference between ERRα and PPARα/RXRα · K MAEHARA and othersamounts of PPAR /RXR (Fig. 4C i and ii) . The intensity of PPAR /RXR -dependent DNAprotein complex was measured and its graphic display is shown in Fig. 4D i and ii. These results indicate that site 1 and site 3 are involved in PPAR /RXR binding while, analogous to the case of ERR , site 2 appears to have little, if any, activity in PPAR /RXR binding. 
Do ERR or PPAR /RXR bind to NRRE-1 as multimers?
In the next step, we tested the possibility that ERR and/or PPAR /RXR could bind to the NRRE-1 as multimers. To answer this question, we performed gel retardation assays using SFRE or NRRE-1 together with increasing amounts of ERR or PPAR /RXR protein expressed in reticulocyte lysates. As shown in Fig. 5A , the position of the DNA-protein complex was different with SFRE or NRRE-1. Although it is not clear, ERR appears to bind to this extended half-site as a monomer (Johnston et al. 1997) . Thus it is likely that ERR binds to NRRE-1 as a homodimer or as two independent monomers. In the case of PPAR /RXR , the position of the DNA-protein complex was similar with both AoxPPRE and NRRE-1 (Fig. 5B) . However, the in vivo relevance and significance of this observation are still unanswered and will need more investigations.
Competitive binding between ERR and PPAR /RXR
From the DNA binding analysis using mutations (Figs 3 and 4) , it appears that the binding sites for ERR and PPAR /RXR overlap (site 1 and site 3). We then addressed the question of whether they can compete with each other for the same response element or whether they form a high order complex. To answer this question, in vitro translated PPAR /RXR was then added in a dosedependent manner to the NRRE-1-ERRdependent DNA-protein complex. As shown in Fig. 6 , the addition of PPAR /RXR could dose-dependently compete with ERR binding to NRRE-1. This result implies that PPAR /RXR can compete with ERR for the same response element present in NRRE-1.
ERR counteracts the PPAR /RXR -mediated transcriptional activation
To gain an insight into the cellular significance of the in vitro observation above, we performed transient transfections of HeLa cells with the ERR and/or PPAR /RXR expression vectors and the CAT reporter gene plasmid containing the NRRE-1 response element upstream of the TK-promoter (NRRE-1/pBLCAT2) or the TKpromoter alone (pBLCAT2). In advance, to certify that ERR is expressed in this experimental system, we checked its expression after transfection. RNA was prepared and quantitative RT-PCR was performed using ERR specific primer. As shown in Fig. 7A , transfection of increasing amounts of Interference between ERRα and PPARα/RXRα · K MAEHARA and othersERR expression vectors did indeed increase its mRNA levels. In contrast to this, expression levels of glyceraldehyde phosphate dehydrogenase (shown as GA; Kutoh et al. 1998) were not influenced by ERR expression vectors. This pre-experiment showed that ERR is indeed expressed in our system. Transfection of ERR expression vector slightly increased the TK-promoter activity (Fig. 7B) . ERR had little, if any, effect on the reporter activity driven by NRRE-1 while PPAR /RXR with its agonist, Wy14,643 (Takahashi & Kawada 2001) , increased the same activity by approximately sevenfold (Fig. 7C) . Then, increasing amounts of ERR expression vectors with fixed amounts of PPAR /RXR dose-dependently suppressed the reporter gene activity driven by PPAR /RXR complex with Wy14,643 (Fig. 7D) . These results suggest that ERR counteracts the PPAR /RXR -mediated transcriptional activation within the NRRE-1. Taken together, these in vitro (Fig. 6) and cellular (Fig. 7) experiments suggest that ERR can compete with RXR /PPAR for the NRRE-1 and repress the RXR /PPARmediated transcriptional activity.
There are conflicting data regarding the transcriptional activity of ERR . As mentioned in the Introduction, some groups showed that ERR is a transcriptional repressor while others reported that it is an activator. Differential corepressor recruitment is one mechanism that could explain why ERR can bind its response element without significant transcriptional activities. Thus, we tested the effect of trichostatin A (TSA), a selective inhibitor of histone deacetylase (HDAC) as well as a disruptor of HDAC associated co-repressor complexes (Rosenfeld & Glass 2001) , on the transcriptional repression observed by the expression of ERR . We added TSA in an effort to re-activate the ERR-repressed conditions. However, no consistent data have been obtained (results not shown).
Discussion
DNA binding properties of ERR and PPAR /RXR complex to the NRRE-1 of the human MCAD gene promoter
In the first place, we showed that the PPAR / RXR complex as well as ERR could bind to NRRE-1 which was shown to be essential for high levels of expression of MCAD gene (Vega & Kelly 1997) . The three potential hexamer half-binding sites (core elements) for nuclear receptors were separated by 8, 14 and 0 bp respectively. Comparison of the DNA sequences and arrangement of NRRE-1 binding sites with the list of other known naturally occurring and artificial ERR or PPAR/RXR response elements (Ijpenberg et al. 1997 , Juge-Aubry et al. 1997 , Sladek et al. 1997 demonstrates that only site 1 matches the proposed consensus binding sequence AGGTCA, whereas site 2 (GGGTAA) and site 3 (AGGTGA) contain a mismatch in the penultimate residue. The hexamer orientation and spacing requirements for elements conferring ERR or PPAR /RXR have not been completely established, although the majority of elements are direct repeats. The mutational analysis of the NRRE-1 shown here demonstrated that the active sites for nuclear receptor binding (site 1 and site 3) have an everted repeat motif with site 1 separated from site 3 by 14 bp (Figs 3 and 4 , site 2 appears to be non-functional in binding to Figure 6 Competition between the PAPRα/RXRα complex and ERRα to NRRE-1. Gel retardation assay was performed using the radiolabeled NRRE-1 probe together with fixed amounts of in vitro translated ERRα (3 µl) and increasing amounts of PPARα/RXRα complex (0+0, 1+1, 2+2, 3+3, 4+4 µl). Free probes are shown at the bottom (F) ERR or PPAR /RXR ). This binding half-site arrangement (ER14) is novel compared with other previously reported PPREs or ERR-response elements (Ijpenberg et al. 1997 , Juge-Aubry et al. 1997 , Sladek et al. 1997 . Based on the results from gel retardation assays using mutated NRRE-1 (Figs 4 and 5), our conclusions regarding the importance of these hexamer sites are as follows: site 1-ERR : essential, PPAR /RXR : involved; site 2-ERR : not involved, PPAR /RXR : not involved; site 3-ERR : partially involved only in the presence of intact site 1, PPAR /RXR : involved.
The schematic presentation of this conclusion is illustrated in Fig. 8 .
It is of interest that ERR binds to site 3 only in the presence of an intact site 1, implying a possible dimerization formation with site 1 and site 3. That dimerization is present on the everted repeat with 14 inverted bp (ER14), as distinct from dual monomer co-occupation, is evidenced by the fact that site 3 is occupied only in the presence of an intact site 1. Thus, ERR most probably binds exclusively to site 1 and the dimer binding is necessary for simultaneous occupation of half-sites (site 1 and site 3). In the case of the PPAR /RXR heterodimer complex, it appears to bind site 1 and site 3, everted repeat with 14-interval bp (ER14). One of the explanations of why PPAR /RXR can still bind to NRRE-1, which is mutated either in site 1 or site 3, is that the binding site requirement of this nuclear receptor complex might be rather permissive. Anyhow, it is rather unusual that heterodimer (PPAR /RXR ) or homodimer (ERR ) receptors interact with such long intervals.
Competitive binding and effect of transcription of ERR and PPAR /RXR within NRRE-1
Although ERR and PPAR /RXR may use overlapping but distinct determinants on the NRRE-1, we did not observe a higher order complex containing all three receptors in vitro. Instead, we observed competitive binding between ERR and RXR /PPAR for the same sites within the NRRE-1 (Fig. 6 ). This observation is reflected in the cellular experiment showing that expression of ERR can counteract the transcriptional activation by the RXR /PPAR complex (Fig. 7) . ERR may also form inactive and non-binding heterodimers with PPAR , RXR or other nuclear factors, effectively sequestering these receptors and preventing them from forming heterodimers that normally induce transcriptional activation, leading to an overall repression of transcription. However, the latter mechanism is unlikely, since inhibition by ERR required the integrity of the NRRE-1 (Fig. 7B,C,D) . It is possible, in vivo, that one of the receptors may constitute a predominant component of the complex, because these nuclear receptor expression patterns are distinct among different tissues.
Characterization of individual binding profiles may provide clues to the compositions of the heterogeneous complex.
At the same time, isolation and characterization of endogenous nuclear proteins that bind to NRRE-1, apart from the ones that have already been identified (Carter et al. 1994 , Vega & Kelly 1997 , will be necessary to fully define this transcriptional regulatory mechanism and to delineate the precise upstream regulatory pathways involved in the control of fatty acid oxidation enzyme expression.
Transcriptional and physiological properties of ERR on MCAD gene: an hypothesis ERR was reported to regulate the promoters of lactoferrin (Yang et al. 1996) , MCAD (Vega & Kelly 1997) , osteopontin (Bonnelye et al. 1997) or TR (Vanacker et al. 1998) in transient transfection assays. ERR generally represses gene transcription in these assays (Sladek et al. 1997) as well as in cell-free systems (Wiley et al. 1993 , Johnston et al. 1997 , and has also been shown to antagonize the action of GR via an unknown mechanism (Trapp & Holsboer 1996) . The lack of ERR transcriptional activity may be due to the absence of its cognate ligand. However, under certain conditions, ERR was reported to activate transcription (Vanacker et al. 1998) . These authors (Vanacker et al. 1998) reported that the transcriptional activity observed is dependent on a serum compound that was withdrawn by charcoal treatment. We were not able to reproduce this data of transactivation in HeLa, HepG2 or SK-N-MC cells (results not shown). It may be that ERR ligand is present in certain serum preparations but not in others. Taken together, it appears that ERR can exert pleiotropic transcriptional controls depending on the targeted promoter and on the cell type considered. However, its mechanism remains completely unknown.
NRRE-1 is crucial for MCAD expression in transgenic models (Vega & Kelly 1997) . Transcriptional regulation via NRRE-1 appears to be a net aggregate response manifested, in part, by the availability of ERR and other factors that bind to NRRE-1, the complexity of response elements and the interplay of ERR with other nuclear hormone receptors. It can be proposed that ERR can influence the MCAD expression through interaction with these nuclear receptors. Our hypothesis is that ERR acts as a transcriptional repressor by competing with the RXR /PPAR complex (or other activators that interact with NRRE-1) for the same sequence within the NRRE-1. Physiological evidence for this model comes from the ERR -deficient mice (Giguere 1999) . They are smaller than the wild-type and show decreased fat content throughout their bodies. Probably due to the absence of ERR that acts as a repressor of the MCAD gene through NRRE-1, other activators (e.g. RXR /PPAR ) could occupy the NRRE-1 and drive out high rates of transcription of MCAD gene, thereby inducing the high rate of -oxidation. Our data of this comparative profile demonstrate that this receptor may interact with elements possessing a wide variety of architectures, a phenomenon consistent with the hypothesis that it acts as a general suppressor of many genes. In this hypothesis, the structure of ERR bound to NRRE-1 or its response element would be relatively permissive for corepressor binding. It is also possible that allosteric effects of the DNA binding site could alter interactions with co-activators or with other DNA-bound transcription factors. Although we failed to show re-activation of the ERRdependent repression with the addition of TSA, it remains to be determined whether such DNAinduced conformational changes can alter coactivator or co-repressor binding. As yet, the transcriptional regulation of ERR remains largely unknown, despite the fact that this was the first nuclear orphan receptor identified many years ago (Giguere et al. 1988) . Ligands of this receptor may change its transcriptional activity thereby influencing the expression of the target genes by ERR , including the MCAD gene which is an important regulator of the rate of fatty acid -oxidation and lipid metabolism. Selective ligands for ERR may change the net transcriptional activity of the MCAD gene through NRRE1, thereby influencing lipid metabolism through -oxidation. To this end, it is important to monitor the effect of ERR on the whole MCAD gene promoter.
